Introduction
============

Blue rubber bleb nevus syndrome (BRBNS) is a rare disorder characterized by venous malformations of the skin, gastrointestinal (GI) tract, and less commonly of other tissues in the body. We present the case of a 59-year-old man and a review of current literature to illuminate the diversity of ophthalmic symptoms, as well as potential treatment options for patients with blue rubber bleb nevus syndrome.

Case report
===========

The patient was initially diagnosed with a familial case of blue rubber bleb nevus syndrome as a child after developing multiple cutaneous lesions on his back, chest, face, and extremities. No major complications from the disease were apparent until July, 2012 (apart from mild anemia), when he presented to his local hospital with loss of vision in his right eye, and chronic pain in the left eye. Preliminary ophthalmic examination revealed significant proptosis and elevated intraocular pressure of the left eye. Magnetic resonance angiography (MRA) revealed a dural arteriovenous fistula (DAVF) in the left skull base (Figure 1 [(Fig. 1)](#F1){ref-type="fig"}).

A total of three endovascular embolization procedures were used to treat the patient's ophthalmic symptoms. Partial occlusion of the DAVF after the first procedure failed to alleviate all of his optic symptoms, as the patient developed morning blurriness and diplopia. After two further operations, the patient is now stable and reports improved symptoms. He appears to have slight pallor of the optic nerves, as well as imbalance and vertigo, but his overall health has greatly improved.

Discussion
==========

Blue rubber bleb nevus syndrome is a very unusual disease with multiple manifestations. Approximately 200 reports of the syndrome have been documented to date \[[@R1]\]. Although some forms appear to have an autosomal dominant inheritance pattern linked to chromosome 9p, the majority of cases are sporadic \[[@R2]\]. Patients often present with small, compressible lesions of the skin and chronic anemia from gastrointestinal bleeding \[[@R3]\]. Diagnosis of the disease usually occurs from these common presentations as well as histological analysis. Radical resection has had positive results in patients with gastrointestinal hemorrhage, and laser therapy has shown promise for cutaneous lesions \[[@R4]\], \[[@R5]\]. However, no pharmaceutical intervention has been proven universally successful in combating BRBNS.

We present here some of the few cases of ophthalmic symptoms associated with this disorder (Table 1 [(Tab. 1)](#T1){ref-type="fig"}). Past reports of orbital involvement of blue rubber bleb nevus syndrome have presented with a myriad of symptoms including: proptosis, enophthalmos, ptosis, vision loss, imbalance, occipital headaches, ecchymosis, and intraocular pressure. Ophthalmic symptoms can be chronic or acute in nature, as with the case of a sudden intraorbital hemorrhage \[[@R6]\]. Cutaneous lesions were also present in most patients (10/11 cases), and gastrointestinal lesions in a subset of reports (5/11 cases). It can be difficult to differentiate BRBNS from Mafucci's syndrome, Klippel-Trenaunay syndrome, diffuse neonatal angiomatosis, and Rendu-Osler-Weber syndrome \[[@R3]\]. Based on our analysis, the common orbital symptoms of blue rubber bleb nevus syndrome may include: the presence of cutaneous venous malformations, chronic anemia, decreased visual acuity, and proptosis or enopthalmos of the eye.

Systemic therapy has not yet successfully treated optic cases of BRBNS, but has achieved varied outcomes in other forms of the disease. Multiple reports have shown interferon-α and corticosteroids to be unsuccessful in long-term treatment of multi focal, large GI lesions \[[@R4]\], \[[@R7]\]. However, recent publications have suggested that sirolimus may be beneficial in the treatment of gastrointestinal bleeds and anemia \[[@R7]\], \[[@R8]\]. Therapy with sirolimus can cause many side effects including hypertension, immunosuppression, renal failure, anemia and hyperlipidemia. In these cases no significant adverse symptoms were recorded except for a slight elevation in cholesterol in one patient. Sirolimus was used in combination with propranolol to reduce adverse effects, but cutaneous lesions and melena were noted 10 days after the physicians attempted to wean the patient off the medication \[[@R7]\]. This agent may, therefore, be considered for short-term treatment of ophthalmic forms of BRBNS, but prolonged use of the drug may be needed to successfully reduce symptoms. Unfortunately, long-term use of sirolimus will likely expose patients to the potential adverse side effects of the drug.

Surgical treatment of chronic ophthalmic manifestations has been successful in our case as well as the other patients in our literature review \[[@R3]\], \[[@R9]\]. Endovascular embolization has been used to alleviate symptoms in patients presenting with dural arteriovenous fistulas, and surgical excision with other venous malformations in the orbit. Embolization procedures have reduced symptoms in all the cases presented, but multiple procedures were often required \[[@R9]\]. Understanding the critical symptoms and potential treatment options will optimize the management of patients with this extremely rare disease and hopefully lead to improved outcomes.

Notes
=====
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